Stay updated on Intratumoral IMO-2125 in Refractory Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Intratumoral IMO-2125 in Refractory Solid Tumors Clinical Trial page.

Latest updates to the Intratumoral IMO-2125 in Refractory Solid Tumors Clinical Trial page
- Check5 days agoChange DetectedRevision label changed from v3.6.4 to v3.6.5, indicating a minor update to the page's revision history. This reflects maintenance work rather than changes to the study data or user-facing content.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedRevision number updated from v3.6.3 to v3.6.4, indicating a recent update to the page's underlying platform or content management. This is a minor release rather than a substantive change to visible content.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedThe page's revision metadata was updated from v3.6.2 to v3.6.3, indicating a software update behind the page. This change does not appear to alter the study content or its visible information.SummaryDifference0.1%

- Check48 days agoChange DetectedThe page now shows Revision: v3.6.2, replacing the previous Revision: v3.6.0. This indicates a small front-end or documentation update.SummaryDifference0.1%

- Check62 days agoChange DetectedNew guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and a recruitment status note were added, and the Intervention/Treatment heading formatting was updated while the revision version was bumped to v3.6.0, signaling a UI/content refresh of the study page.SummaryDifference0.4%

- Check69 days agoChange DetectedFooter now shows Revision: v3.5.5, signifying a new page revision. This is a small update to the page’s metadata rather than a change in the study details or user-facing features.SummaryDifference0.1%

Stay in the know with updates to Intratumoral IMO-2125 in Refractory Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intratumoral IMO-2125 in Refractory Solid Tumors Clinical Trial page.